April 2022
Tips and tricks in interpretation of clinical trials
Prof. Petar M. Seferović
University of Belgrade Faculty of Medicine – Belgrade, Serbia
Dr. Ivan Milinković
University of Belgrade Faculty of Medicine – Belgrade, Serbia
The podcast discusses how major clinical trials changed the perspective on how randomized clinical trials are designed, conducted and interpreted. It gives the insight into major positive and negative aspects of the clinical trials, which results influenced the contemporary heart failure treatment
March 2022
Implementing the use of HF treatments in clinical practice
Prof. Gianluigi Savaresse
Karolinska Institute – Stockholm, Sweden
Dr. Otilia Țica
Emergency County Hospital of Oradea - Oradea, Romania
This podcast will discuss the optimal implementation of heart failure therapies: guidelines, and challenges. It tackled how registries support implementation of care and trial design in heart failure. Prof. Gianluigi Savaresse interviewed by Dr Otilia Țica, member of HOT committee, will guide us throughout the challenges of implementing optimal therapies in HF and will offer an insight on how registries can help directly improve quality of care.
February 2022
The SGLT2-inhibitors revolution in Heart Failure. Current indications and future perspectives
Giuseppe Rosano
St George's Hospital Medical School – London, UK
Dr. Antonio Cannata
King's College London - London, UK
This podcast will discuss the most recent and serendipitous revolution in the field of Heart Failure, the SGLT2-inhibitors, their indications and future perspectives. Prof Rosano, interviewed by Dr Cannata, will drive through the most recent evidence supporting the use of SGLT2-i in patients with heart failure. Let's see whether an apple a day truly keeps the doctor away.
January 2022
Medical treatment for heart failure. News and controversies from 2021 ESC heart failure Guidelines
Prof. Ewa A. Jankowska
Wroclaw Medical University - Wroclaw, Poland
Mateusz Sokolski
Wroclaw Medical University - Wroclaw, Poland
The podcast presents the news and controversies related to 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. The discussion between co-author of the guidelines and member of HOT Committee covers the important clinical aspects of medical treatment of heart failure and co-morbidities taking into account some doubts coming from guidelines and gaps in evidence.
Our mission: To reduce the burden of cardiovascular disease.